One commonly cited formulation lists 50 mg GHK-Cu, 10 mg KPV, 10 mg BPC-157, and 10 mg TB-500 per vial , for a total of 80 mg , with GHK-Cu accounting for 62.5% of the blend and each of the other three peptides contributing 12.5% by mass, according to Protide Healths KLOW peptide guide
Clinically, this manifests as impaired flow-mediated dilation (FMD) and elevated biomarkers like asymmetric dimethylarginine (ADMA), an endogenous eNOS inhibitor (Kavurma et al., 2022)
This direct delivery method is particularly beneficial for individuals with conditions that affect nutrient absorption, such as Crohns disease or pernicious anemia
Numbness, tingling, or a pins-and-needles sensation
Understanding BPC-157 and Peptide Therapy BPC-157, short for Body Protection Compound-157 , is a synthetic peptide derived from a naturally occurring protein in human gastric juice